UT-MD Anderson Cancer Center: ASH - Novel Menin Inhibitors Show Promise for Patients With Advanced Acute Myeloid Leukemias
December 11, 2023
December 11, 2023
HOUSTON, Texas, Dec. 11 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
Two MD Anderson-led trials demonstrate encouraging activity for leukemias with specific genetic mutations
* * *
ABSTRACTS: 57, 58
Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early positive results from novel therapies targeting menin for the t . . .
* * *
Two MD Anderson-led trials demonstrate encouraging activity for leukemias with specific genetic mutations
* * *
ABSTRACTS: 57, 58
Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early positive results from novel therapies targeting menin for the t . . .